Imaging News

WASHINGTON — In a head-to-head trial, PCI guided by fractional flow reserve was noninferior to PCI guided by IVUS for death, MI and revascularization at 2 years, researchers reported at the American College of Cardiology Scientific Session.

WASHINGTON — The 5-year rate of structural valve deterioration was lower in self-expanding valves for transcatheter aortic valve replacement than in surgical valves, researchers reported.

WASHINGTON — In a new study, subcutaneous biweekly alirocumab, added to high-intensity statin therapy, resulted in greater coronary plaque regression in non-infarct-related arteries after 1 year in patients with acute MI.

WASHINGTON — In the first randomized trial of a therapy for treatment of patients with angina and nonobstructive CAD, diltiazem did not improve coronary vasomotor dysfunction compared with placebo.

The 2022 American College of Cardiology Scientific Session will be held live in Washington, D.C., from April 2 to 4, and virtually, with 39 late-breaking trials and featured clinical research presentations.

Breast arterial calcification seen on a routine mammogram may independently predict atherosclerotic CVD and global CVD risk for postmenopausal women, according to research published in Circulation: Cardiovascular Imaging.

Circa Scientific announced it received FDA clearance for U.S. sale of its esophageal temperature probe.

The FDA has issued a letter to health care providers emphasizing the importance of annual follow-up in patients who received endovascular grafts for abdominal aortic aneurysm.

Dyad Medical announced its automated image analysis tool to view and quantify intravascular OCT images has been granted clearance by the FDA.

Philips announced the FDA clearance and launch of a new version of its point-of-care hand-held ultrasound for CV and other applications.